Halozyme Therapeutics (HALO) News Today $58.24 -0.53 (-0.90%) Closing price 04:00 PM EasternExtended Trading$58.25 +0.01 (+0.02%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HALO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Halozyme Therapeutics, Inc.: European Commission Approved DARZALEX Faspro for Adult Patients with Smouldering Multiple MyelomaJuly 24 at 12:51 AM | finanznachrichten.deJ&J says Darzalex injectable granted EU nod for smouldering multiple myelomaJuly 24 at 12:51 AM | msn.comEuropean Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple MyelomaJuly 24 at 12:51 AM | finance.yahoo.comEuropean Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple MyelomaJuly 23 at 11:44 AM | prnewswire.comConvergence Investment Partners LLC Lowers Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 23 at 8:08 AM | marketbeat.comAdvisors Preferred LLC Has $3.44 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 23 at 7:45 AM | marketbeat.comReadystate Asset Management LP Has $5.72 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 23 at 6:12 AM | marketbeat.comPier 88 Investment Partners LLC Buys New Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 22 at 11:41 AM | marketbeat.comHalozyme to Report Second Quarter 2025 Financial and Operating ResultsJuly 22 at 8:30 AM | prnewswire.comGW&K Investment Management LLC Sells 280,750 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 21, 2025 | marketbeat.comHorizon Investment Services LLC Grows Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 21, 2025 | marketbeat.comVictory Capital Management Inc. Sells 27,731 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 20, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Bernzott Capital AdvisorsJuly 18, 2025 | marketbeat.comDakota Wealth Management Makes New $396,000 Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 18, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Price Target Raised to $60.00July 18, 2025 | americanbankingnews.comJPMorgan Chase & Co. Increases Halozyme Therapeutics (NASDAQ:HALO) Price Target to $60.00July 16, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Position Increased by James Investment Research Inc.July 16, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $21.90 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 16, 2025 | marketbeat.comTectonic Advisors LLC Raises Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 15, 2025 | marketbeat.comKornitzer Capital Management Inc. KS Cuts Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 15, 2025 | marketbeat.comHalozyme: Is Robust Growth Masking A Long-Term Value Trap? (Rating Downgrade)July 14, 2025 | seekingalpha.comEdgestream Partners L.P. Buys 119,183 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 14, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Position Cut by Cerity Partners LLCJuly 14, 2025 | marketbeat.comStephens Investment Management Group LLC Trims Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 13, 2025 | marketbeat.comBrown Advisory Inc. Has $2.22 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 13, 2025 | marketbeat.comM&T Bank Corp Reduces Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 12, 2025 | marketbeat.comCaas Capital Management LP Acquires Shares of 4,700 Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 11, 2025 | marketbeat.comInsider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells 20,000 Shares of StockJuly 11, 2025 | insidertrades.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Helen Torley Sells 20,000 SharesJuly 10, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Now Covered by The Goldman Sachs GroupJuly 10, 2025 | marketbeat.comHALO - Halozyme Therapeutics Inc Trailing Returns - MorningstarJuly 9, 2025 | morningstar.comMHarvey Capital Management Inc. Has $9.52 Million Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 9, 2025 | marketbeat.comHere's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 YearsJuly 8, 2025 | benzinga.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Allspring Global Investments Holdings LLCJuly 7, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Receives Average Rating of "Hold" from BrokeragesJuly 7, 2025 | marketbeat.comHALO - Halozyme Therapeutics Inc Financials - MorningstarJuly 5, 2025 | morningstar.comMMoody Aldrich Partners LLC Has $6.17 Million Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 4, 2025 | marketbeat.comHALO - Halozyme Therapeutics Inc Valuation - MorningstarJuly 3, 2025 | morningstar.comMMeritage Portfolio Management Buys Shares of 101,651 Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 3, 2025 | marketbeat.comNovem Group Acquires 4,821 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 3, 2025 | marketbeat.comOppenheimer & Co. Inc. Takes $625,000 Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)July 1, 2025 | marketbeat.comHalozyme Therapeutics Added to Russell 1000® IndexJune 30, 2025 | prnewswire.comZacks Research Issues Pessimistic Forecast for HALO EarningsJune 30, 2025 | marketbeat.comArtemis Investment Management LLP Purchases Shares of 125,652 Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 28, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Acquired by Spire Wealth ManagementJune 28, 2025 | marketbeat.comHalozyme Therapeutics Inc (RV7.SG)June 26, 2025 | uk.finance.yahoo.comVictory Diversified Stock Fund Q1 2025 CommentaryJune 26, 2025 | seekingalpha.comEnvestnet Portfolio Solutions Inc. Has $721,000 Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)June 26, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells $1,059,200.00 in StockJune 25, 2025 | insidertrades.comHelen Torley Sells 20,000 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) StockJune 24, 2025 | marketbeat.com Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address HALO Media Mentions By Week HALO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HALO News Sentiment▼1.181.06▲Average Medical News Sentiment HALO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HALO Articles This Week▼1312▲HALO Articles Average Week Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIIB News Today UTHR News Today NBIX News Today INCY News Today EXEL News Today BMRN News Today EXAS News Today MDGL News Today IONS News Today RGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HALO) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HALO Stock Alerts